Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

The Effect of Art-Based Intervention on Fatigue, Anxiety, Perception of Nurse Presence, and Quality of Life in Patients With Hematological Cancers

NCT07551817 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-04-27

Condition(s) studied

Art-based InterventionHematological CancerNurse PresenceQuality of LifeFatigueAnxiety

Investigational drug(s) / intervention(s)

art-based intervention

art-based intervention: The Art-Based Intervention program will be implemented in 3 sessions per week, for a total of 6 sessions. Before starting the Art-Based Intervention program, the researcher will provide information about the purpose of the activity and the tools to be used. Each session will have a theme, and the session will be conducted according to the instructions given to the patient within the framework of this theme. Before each session, the theme specific to that day will be explained to the patients. Sessions will last approximately 45 minutes.

Study summary

This study will be conducted in a randomized controlled experimental design to examine The effect of art-based intervention on fatigue, anxiety, perception of nurse presence, and quality of life in patients with hematological cancer. The study will be conducted with 52 patients (26 intervention, 26 control groups) treated in the Hematology department of a training and research hospital between May 2025 and October 2026. Art-based intervention will be applied to the intervention group for 2 week (3 sessions per week), No application will be made to the control group. The data collection tools in the study are the Patient Identifier Information Form, Cancer Fatigue Scale, Functional Assessment of Cancer Therapy-General Scale (FACT-G), Hospital Anxiety and Depression Scale (HADS), and Nurse Presence Scale (PONS).

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being between 18 and 65 years of age * Speaking and understanding Turkish * Being literate * Having a diagnosis of hematological cancer, * Receiving chemotherapy in an inpatient ward, * Not having a psychiatric diagnosis, * Having an ECOG score of 1 or 2, Exclusion Criteria: * Having vision loss and hearing loss, * Having an ECOG score of 3 or 4 * Patients who wanted to leave the study * Failure to attend at least two sessions of art therapy.

Primary outcome measure(s)

  • Functional Assessment of Cancer Therapy-General Scale (FACT-G) — 0 st day (before intervention); 14 st day (after intervention) and 28 st day (after intervention).
    It is a system based on health-related quality of life measurements. FACT-G consists of four sub-dimensions and 27 items: physical condition, social life and family condition, emotional condition, and activity status. The sub-dimension scores of the 27-item, five-point Likert-type scale are evaluated as follows: none: 0, very little: 1, somewhat: 2, quite: 3, very much: 4. The score ranges are 0 to 28, 0 to 28, 0 to 24, and 0 to 28 for the physical condition, social life and family condition, emotional condition, and activity status subscales, respectively. The maximum total score that can be obtained from the scale is 108, and the minimum score is 0.
  • Cancer Fatigue Scale — 0 st day (before intervention); 14 st day (after intervention) and 28 st day (after intervention).
    This 5-point Likert-type scale consists of three sub-sections: physical, emotional, and cognitive, totaling 15 items. The highest possible score is 28 for the physical dimension, 16 for the emotional dimension, and 16 for the cognitive dimension, for a total of 60 points.
  • Hospital Anxiety and Depression Scale (HADS) — 0 st day (before intervention); 14 st day (after intervention) and 28 st day (after intervention).
    Designed to assess patients' mental health and take necessary precautions. It is a 14-item, 4-point Likert-type scale. Each item has a different score. Items 1, 3, 5, 6, 8, 10, 11, and 13 show decreasing severity and are scored as 3, 2, 1, 0; items 2, 4, 7, 9, 12, and 14 are scored as 0, 1, 2, 3. For anxiety, patients scoring between 0-10 are interpreted as having no anxiety, and those scoring 11 and above are interpreted as having anxiety. For depression, patients scoring between 0-7 are interpreted as having no depression, and those scoring 8 and above are interpreted as having depression.
  • Nurse Presence Scale — 0 st day (before intervention); 14 st day (after intervention) and 28 st day (after intervention).
    The scale measures nurse presence with 26 items and patient satisfaction with the last two items. Each item is scored as follows: never (1 point), rarely (2 points), sometimes (3 points), frequently (4 points), and always (5 points). An increase in the score indicates that the nurse's presence and the behaviors she provides are increasing, and patients perceive this positively.

Trial sites (1)

FacilityCityRegionStatus
Gazi University Ankara Çankaya
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07551817 on ClinicalTrials.gov ↗ ← All trials in Turkey